The efficacy of PD-1 antibody sintilimab on ground glass opacity lesions in patients with early-stage multiple primary lung cancer (CCTC-1901, NCT04026841).

已取消 10 由熙熙发布于 2024/12/23 9:03:35

DOI:10.1200/JCO.2021.39.15_SUPPL.8545
作者：B. Cheng,?Caichen Li,?Yi Zhao,?Jianxing He
文献类型：期刊论文
补充材料：只需要正文
管理员驳回:超时未应助，系统关闭。如求助信息不完整（标题、DOI、原文链接），可以补充后重新发布求助。

American Society of Clinical Oncology (ASCO)

Abstract：8545 Background: Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1) have been proven its significant efficacy on advanced non-small cell lung cancer (NSCLC)

应助信息

2024-12-23

Book学术机器人

2024/12/23 9:03:35 未找到该文献，机器人已退出，请等待人工下载

2024/12/23 9:03:35 Book学术AI机器人收到请求，开始寻找文献

2024/12/23 9:03:35 已向机器人发送请求

2024-12-23

熙熙发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyPromising Mass-Productive 4-Inch Commercial SERS Sensor with Particle in Micro-Nano Porous Ag/Si/Ag Structure Using in Auxiliary Diagnosis of Early Lung Cancer